Localization of amyloid P component in human brain: Vascular staining patterns and association with alzheimer's disease lesions
- 30 January 1995
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 352 (1) , 92-105
- https://doi.org/10.1002/cne.903520107
Abstract
Amyloid P component is a normal serum protein that is highly conserved across phylogeny. Although it resembles the classic acute-phase reactant C-reactive protein, and is considered to be a normal extracellular matrix component, its physiologic role in humans is unknown. Amyloid P component is also colocalized with accumulations of all recognized forms of amyloid. The present study uses light and electron microscopy to compare the cerebral localization of amyloid P component in cases with (n = 19) and without (n = 15) Alzheimer's disease (AD). In non-AD cases, amyloid P component was predominantly localized to the cerebrovasculature. Perivascular staining was observed in most cases, more so in the white than in the gray matter. In AD cases, amyloid P component was localized to all three characteristic histopathologic lesions, namely, neurofibrillary tangles, senile plaques, and amyloid angiopathy. Furthermore, in cases with prominent staining of gray matter parenchymal lesions, intravascular staining was decreased. Given the fixation and processing methods used, amyloid P component was never seen to be localized to the cerebrovascular basement membrane. These data argue against amyloid P component's postulated role as the anchor for vascular β-amyloid deposition. Because there is no evidence for intrinsic amyloid P component production in brain, its perivascular and parenchymal distributions suggest either compromise of the blood-brain barrier or transport across vascular endothelium.Keywords
This publication has 57 references indexed in Scilit:
- Apolipoprotein E: Binding to Soluble Alzheimer′s β-AmyloidBiochemical and Biophysical Research Communications, 1993
- Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in alzheimer's diseaseBiochemical and Biophysical Research Communications, 1992
- Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer DiseaseJournal of Neurochemistry, 1989
- A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tanglesNeuroscience Letters, 1989
- A CASE OF FAMILIAL, ATYPICAL ALZHEIMER'S DISEASE: IMMUNOHISTOCHEMICAL STUDY OF AMYLOID P–COMPONENTNeuropathology and Applied Neurobiology, 1988
- Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigensAnnals of Neurology, 1988
- Lack of evidence for dysfunction of the blood-brain barrier in Alzhiemer's disease: An immunohistochemical studyNeurobiology of Aging, 1988
- Examination of Blood — Brain Barrier Permeability in Dementia of the Alzheimer Type with [68Ga]EDTA and Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1987
- Fibronectin binds to amyloid P component. Localization of the binding site to the 31,000 dalton C-terminal domainBiochemical and Biophysical Research Communications, 1986
- IMMUNOHISTOCHEMICAL STAINING OF SENILE PLAQUESNeuropathology and Applied Neurobiology, 1982